GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » EBIT per Share

Nortem Biogroup (XPAR:MLBIO) EBIT per Share : € (TTM As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup EBIT per Share?

Nortem Biogroup's EBIT per Share for the six months ended in Dec. 2022 was €0.25. Nortem Biogroup does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2022.

During the past 12 months, the average EBIT per Share Growth Rate of Nortem Biogroup was -17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nortem Biogroup's EBIT per Share or its related term are showing as below:

XPAR:MLBIO's 3-Year EBIT Growth Rate is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 5.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Nortem Biogroup's EBIT for the six months ended in Dec. 2022 was €0.64 Mil.

Nortem Biogroup EBIT per Share Historical Data

The historical data trend for Nortem Biogroup's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup EBIT per Share Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
EBIT per Share
0.31 0.25

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
EBIT per Share 0.31 0.25

Nortem Biogroup EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nortem Biogroup's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

EBIT per Share(A: Dec. 2022 )
=EBIT/Shares Outstanding (Diluted Average)
=0.638/2.579
=0.25

Nortem Biogroup's EBIT per Share for the quarter that ended in Dec. 2022 is calculated as

EBIT per Share(Q: Dec. 2022 )
=EBIT/Shares Outstanding (Diluted Average)
=0.638/2.579
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nortem Biogroup  (XPAR:MLBIO) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Nortem Biogroup EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » EBIT per Share
Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Website
https://www.nortembiogroup.com
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines